Elisabeth Brouwer

18.0k total citations · 3 hit papers
240 papers, 9.4k citations indexed

About

Elisabeth Brouwer is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Elisabeth Brouwer has authored 240 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Rheumatology, 111 papers in Pulmonary and Respiratory Medicine and 91 papers in Immunology. Recurrent topics in Elisabeth Brouwer's work include Vasculitis and related conditions (105 papers), Rheumatoid Arthritis Research and Therapies (56 papers) and Systemic Lupus Erythematosus Research (41 papers). Elisabeth Brouwer is often cited by papers focused on Vasculitis and related conditions (105 papers), Rheumatoid Arthritis Research and Therapies (56 papers) and Systemic Lupus Erythematosus Research (41 papers). Elisabeth Brouwer collaborates with scholars based in Netherlands, United Kingdom and United States. Elisabeth Brouwer's co-authors include Cees G. M. Kallenberg, Kornelis S. M. van der Geest, Suzanne Arends, Wayel H. Abdulahad, Arjan Vissink, Minke G. Huitema, Johanna Westra, Peter Heeringa, Jan J. Weening and Bhaskar Dasgupta and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Elisabeth Brouwer

231 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trial of Tocilizumab in Giant-Cell Arteritis

2017 815 citations Elisabeth Brouwer et al. profile →
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

2018 577 citations Elisabeth Brouwer, Riemer H. J. A. Slart et al. profile →
ANCA-associated vasculitis

2020 499 citations A. Richard Kitching, Hans‐Joachim Anders et al. Nature Reviews Disease Primers profile →

Peers

Countries citing papers authored by Elisabeth Brouwer

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Brouwer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Brouwer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Brouwer more than expected).

Fields of papers citing papers by Elisabeth Brouwer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Brouwer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Brouwer. The network helps show where Elisabeth Brouwer may publish in the future.

Co-authorship network of co-authors of Elisabeth Brouwer

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Brouwer. A scholar is included among the top collaborators of Elisabeth Brouwer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Brouwer. Elisabeth Brouwer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritis 2025 ·Lara D. Veeken ·Shuang Xu, William F. Jiemy, Yannick van Sleen, Johanna Westra, (unknown), Kornelis S. M. van der Geest, Peter Heeringa, Annemieke M. H. Boots, Elisabeth Brouwer, Maria Sandovici	0
2	Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends 2024 ·Seminars in Nuclear Medicine ·Kornelis S. M. van der Geest, Olivier Gheysens, Lars Christian Gormsen, Andor W.J.M. Glaudemans, Charalampos Tsoumpas, Elisabeth Brouwer, P. H. Nienhuis, (unknown), Riemer H. J. A. Slart	17
3	Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement 2024 ·Lara D. Veeken ·(unknown), Elisabeth Brouwer, Riemer H. J. A. Slart, Maria Sandovici, Abraham Rutgers, (unknown), Birgitta I. Hiddinga, Sjoukje F. Oosting, Mathilde Jalving, (unknown), (unknown), Geke A.P. Hospers, Kornelis S. M. van der Geest	10
4	Increased Diagnostic Accuracy of the Labial Gland Biopsy in Primary Sjögren Syndrome When Multiple Histopathological Features Are Included 2023 ·Arthritis & Rheumatology ·(unknown), (unknown), Suzanne Arends, Erlin A. Haacke, S.C. Liefers, Gwenny M. Verstappen, Jolien F. van Nimwegen, Elisabeth Brouwer, Alja J. Stel, Fred K. L. Spijkervet, Arjan Vissink, Hendrika Bootsma, Bert van der Vegt, Frans G. M. Kroese	9
5	Comparing Diagnostic Performance of Short and Long [18F]FDG-PET Acquisition Times in Giant Cell Arteritis 2023 ·Diagnostics ·P. H. Nienhuis, (unknown), (unknown), (unknown), Edgar M. Colin, Kornelis S. M. van der Geest, (unknown), Elisabeth Brouwer, (unknown), Riemer H. J. A. Slart	4
6	Phenotypic, transcriptomic and functional profiling reveal reduced activation thresholds of CD8+ T cells in giant cell arteritis 2022 ·Lara D. Veeken ·(unknown), Kornelis S. M. van der Geest, Maria Sandovici, William F. Jiemy, (unknown), Wayel H. Abdulahad, Annemieke M. H. Boots, Peter Heeringa, Elisabeth Brouwer	13
7	A Review on the Value of Imaging in Differentiating between Large Vessel Vasculitis and Atherosclerosis 2021 ·Journal of Personalized Medicine ·P. H. Nienhuis, (unknown), Andor W.J.M. Glaudemans, Elisabeth Brouwer, Riemer H. J. A. Slart	23
8	Toward Reliable Uptake Metrics in Large Vessel Vasculitis Studies 2021 ·Diagnostics ·(unknown), P. H. Nienhuis, (unknown), (unknown), Kornelis S. M. van der Geest, Elisabeth Brouwer, Andor W.J.M. Glaudemans, Bhanu Sinha, Antoon T. M. Willemsen, Riemer H. J. A. Slart	8
9	A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL‐40/Interleukin‐13 Receptor α2 Axis 2021 ·Arthritis & Rheumatology ·Yannick van Sleen, William F. Jiemy, Sarah Pringle, Kornelis S. M. van der Geest, Wayel H. Abdulahad, Maria Sandovici, Elisabeth Brouwer, Peter Heeringa, Annemieke M. H. Boots	39
10	Ageing enhances cellular immunity to myeloperoxidase and experimental anti-myeloperoxidase glomerulonephritis 2021 ·Lara D. Veeken ·Maliha A. Alikhan, (unknown), (unknown), Kate Robson, Joshua D. Ooi, Elisabeth Brouwer, Peter Heeringa, Stephen R. Holdsworth, A. Richard Kitching	5
11	Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment 2021 ·Journal of Clinical Medicine ·(unknown), William F. Jiemy, Yannick van Sleen, Kornelis S. M. van der Geest, Maria Sandovici, Peter Heeringa, A. Boots, Elisabeth Brouwer	21
12	Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis 2021 ·Lara D. Veeken ·(unknown), William F. Jiemy, Yannick van Sleen, Johan Bijzet, (unknown), P. H. Nienhuis, Riemer H. J. A. Slart, Peter Heeringa, Annemieke M. H. Boots, Elisabeth Brouwer	10
13	ANCA-associated vasculitis breakdown → 2020 ·Nature Reviews Disease Primers ·A. Richard Kitching, Hans‐Joachim Anders, Neil Basu, Elisabeth Brouwer, Jennifer Gordon, David Jayne, Joyce Kullman, Paul Lyons, Peter A. Merkel, Caroline O. S. Savage, Ulrich Specks, Renate Kain	499
14	Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis 2017 ·Scientific Reports ·Yannick van Sleen, Qi Wang, Kornelis S. M. van der Geest, Johanna Westra, Wayel H. Abdulahad, Peter Heeringa, Annemieke M. H. Boots, Elisabeth Brouwer	47
15	Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis 2015 ·PLoS ONE ·Paulina Chalan, Johan Bijzet, Minke G. Huitema, Bart‐Jan Kroesen, Elisabeth Brouwer, Annemieke M. H. Boots	14
16	The Relation Between Daily Physical Activity Measured with the Accelerometer and Clinical Assessments in Patients with Ankylosing Spondylitis 2011 ·Data Archiving and Networked Services (DANS) ·Suzanne Arends, Y.P.T. Kamsma, E. van der Veer, M. K. Leijsma, P. M. Houtman, Cees G. M. Kallenberg, Anneke Spoorenberg, Elisabeth Brouwer, (unknown)	2
17	Role for CaMKII Inhibition in Rheumatoid Arthritis 2009 ·Annals of the New York Academy of Sciences ·Johanna Westra, Elisabeth Brouwer, (unknown), Berber Doornbos‐van der Meer, Marcel D. Posthumus, M. A. van Leeuwen, Pieter C. Limburg, Yutaka Ueda, Cees G. M. Kallenberg	14
18	Van hoogveen- en venherstel naar herstel van een compleet nat zandlandschap 2009 ·Socio-Environmental Systems Modeling ·G.A. van Duinen, Elisabeth Brouwer, (unknown), (unknown), (unknown), Wilco C. E. P. Verberk	0
19	Antimyeloperoxidase-associated Lung Disease: An Experimental Model 1999 ·American Journal of Respiratory and Critical Care Medicine ·Pascal Foucher, Peter Heeringa, Arjen H. Petersen, Minke G. Huitema, Elisabeth Brouwer, Jan Willem Cohen Tervaert, Jochum Prop, (unknown), J J Weening, Cees G. M. Kallenberg	44
20	ROLE OF RENAL ISCHEMIA IN EXPERIMENTAL ANTIMYELOPEROXIDASE NAMPO) ASSOCIATED PROLIFERATIVE GLOMERULONEPHRITIS (GN) 1994 ·Journal of the American Society of Nephrology ·Elisabeth Brouwer, (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact